UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

The lancet oncology, 2014-12, Vol.15 (13), p.1521-1532

2014

Volltextzugriff (PDF)

Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

Clinical cancer research, 2012-04, Vol.18 (7), p.2108-2114

2012

Volltextzugriff (PDF)

Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy

Cancer, 2012-08, Vol.118 (16), p.4053-4062

2012

Volltextzugriff (PDF)

Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation

Cancer research (Chicago, Ill.), 2017-03, Vol.77 (6), p.1310-1321

2017

Volltextzugriff (PDF)

A tiling resolution DNA microarray with complete coverage of the human genome

Nature genetics, 2004-03, Vol.36 (3), p.299-303

2004

Volltextzugriff (PDF)

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

The Prostate, 2009-07, Vol.69 (10), p.1091-1100

2009

Volltextzugriff (PDF)

Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer

Acta oncologica, 2010-10, Vol.49 (7), p.888-894

2010

Volltextzugriff (PDF)

Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma

The Journal of clinical investigation, 2012-11, Vol.122 (11), p.4025-4036

2012

Volltextzugriff (PDF)

NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy

Clinical cancer research, 2012, Vol.18 (1), p.308-316

2012

Volltextzugriff (PDF)

Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays

BMC genomics, 2004-01, Vol.5 (1), p.6-6, Article 6

2004

Volltextzugriff (PDF)

Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer

Genes chromosomes & cancer, 2004-01, Vol.39 (1), p.93-98

2004

Volltextzugriff (PDF)

114 Stereotactic Body Radiation Therapy (SBRT) and Hypo-Fractionated Radiation Therapy (HFRT) Outcomes for Low and Intermediate-Risk Prostate Cancer (PRCA): Experience at Two Ontario Centres

Radiotherapy and oncology, 2023-09, Vol.186, p.S53

2023

Volltextzugriff (PDF)

198 A Community-Based Orthopedic Radiation Oncology Clinic (OROC): An Early Experience Report

Radiotherapy and oncology, 2019-10, Vol.139, p.S83-S83

2019

Volltextzugriff (PDF)

Biochemical disease control outcomes of stereotactic body radiation therapy (SBRT) or moderate hypo-fractionation (HFRT) for low- and intermediate-risk prostate cancer (PrCa): Retrospective analysis of 12 years of experience at two Canadian cancer centers

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.363-363

2023

Volltextzugriff (PDF)

Abstract 4702: Upgrading cancer immunotherapy: Checkpoint blockade mAb-ODN conjugate

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4702-4702

2018

Volltextzugriff (PDF)

4-1BB Aptamer-Based Immunomodulation Enhances the Therapeutic Index of Radiation Therapy in Murine Tumor Models

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.458-461

2016

Volltextzugriff (PDF)

P1.01-043 Comparison of Gender, Race Distribution, and Survival in the 1990s to 2010s in Lung Cancer Patients at a Single Institution: Topic: Prognostic Factors, Treatment

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S476-S476

2017

Volltextzugriff (PDF)

P1.01-043 Comparison of Gender, Race Distribution, and Survival in the 1990s to 2010s in Lung Cancer Patients at a Single Institution

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S476

2017

Volltextzugriff (PDF)

Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab

Clinical lung cancer, 2018-05, Vol.19 (3), p.280-288.e4

2018

Volltextzugriff (PDF)

Disease control outcomes of stereotactic body radiation therapy or moderate hypo-fractionation for prostate cancer: Real-world experience at two Canadian centers

The Prostate, 2024-02, Vol.84 (2), p.193-202

2024

Volltextzugriff (PDF)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Oncotarget, 2016-08, Vol.7 (33), p.53362-53376

2016

Volltextzugriff (PDF)

Abstract 4992: Development of a novel radiation-induced targeted immunotherapy strategy through oligonucleotide aptamer conjugation

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4992-4992

2016

Volltextzugriff (PDF)

206: A Randomized Phase Ii Trial of Prostate Boost Irradiation with Stereotactic Body Radiotherapy (SBRT) in High-Risk Prostate Cancer. The Pbs Trial

Radiotherapy and oncology, 2020-09, Vol.150, p.S87-S88

2020

Volltextzugriff (PDF)

Identifying a Niche: Development of the Orthopedic Radiation Oncology Clinic

Journal of medical imaging and radiation sciences, 2019-06, Vol.50 (2), p.S2-S2

2019

Volltextzugriff (PDF)

Abstract 1700: Radiation-induced vegf-targeted 4-1bb costimulation enhances immune control of tumor growth

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1700-1700

2017

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy

Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation

A tiling resolution DNA microarray with complete coverage of the human genome

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer

Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma

NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy

Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays

Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer

114 Stereotactic Body Radiation Therapy (SBRT) and Hypo-Fractionated Radiation Therapy (HFRT) Outcomes for Low and Intermediate-Risk Prostate Cancer (PRCA): Experience at Two Ontario Centres

198 A Community-Based Orthopedic Radiation Oncology Clinic (OROC): An Early Experience Report

Biochemical disease control outcomes of stereotactic body radiation therapy (SBRT) or moderate hypo-fractionation (HFRT) for low- and intermediate-risk prostate cancer (PrCa): Retrospective analysis of 12 years of experience at two Canadian cancer centers

Abstract 4702: Upgrading cancer immunotherapy: Checkpoint blockade mAb-ODN conjugate

4-1BB Aptamer-Based Immunomodulation Enhances the Therapeutic Index of Radiation Therapy in Murine Tumor Models

P1.01-043 Comparison of Gender, Race Distribution, and Survival in the 1990s to 2010s in Lung Cancer Patients at a Single Institution: Topic: Prognostic Factors, Treatment

P1.01-043 Comparison of Gender, Race Distribution, and Survival in the 1990s to 2010s in Lung Cancer Patients at a Single Institution

Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab

Disease control outcomes of stereotactic body radiation therapy or moderate hypo-fractionation for prostate cancer: Real-world experience at two Canadian centers

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Abstract 4992: Development of a novel radiation-induced targeted immunotherapy strategy through oligonucleotide aptamer conjugation

206: A Randomized Phase Ii Trial of Prostate Boost Irradiation with Stereotactic Body Radiotherapy (SBRT) in High-Risk Prostate Cancer. The Pbs Trial

Identifying a Niche: Development of the Orthopedic Radiation Oncology Clinic

Abstract 1700: Radiation-induced vegf-targeted 4-1bb costimulation enhances immune control of tumor growth

Suchergebnisse filtern